{
  "ticker": "MDR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968457",
  "id": "02968457",
  "pages": 7,
  "price_sensitive": false,
  "date": "20250711",
  "time": "0906",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250711/pdf/06lpxkvjgtzxy8.pdf",
  "summary": "### Summary of ASX Announcement:  \n\n- **Announcement Type**: Appendix 2A - Application for quotation of securities (new issuance from options exercise).  \n- **Company**: MedAdvisor Limited (ASX: MDR).  \n Thus **Securities Issued**: 469,046 new fully paid ordinary shares (MDR) from option conversions.  \n- **Exercise Details**:  \n  - Derived from options (MDRAI) exercised between **8 May 2025 \u2013 9 July 2025**.  \n  - Includes **433,000 shares** issued to a KMP-associated superfund (Ancila Desai / NTD Superfund Pty Ltd).  \n  - **No cash consideration** (nil AUD value per security disclosed).  \n- **Post-Issuance Capital Structure**:  \n  - **Total ordinary shares on issue**: 625,254,103 (quoted).  \n  - **Outstanding unquoted options**: Multiple tranches (~59.4M total) with varying strike prices and expiries.  \n\n**Key Implications**:  \n- Minimal dilution impact (<0.1% of issued capital).  \n- No cash inflow to company (potential overhang risk if KMP-linked shares are sold).  \n\nNo other material information identified.",
  "usage": {
    "prompt_tokens": 1895,
    "completion_tokens": 263,
    "total_tokens": 2158,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-10T23:21:07.877883"
}